An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis

Título:	An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis
Autores/as:	Lekamwasam, S. Adachi, J. D. Agnusdei, D. Bilezikian, J. Boonen, S. Borgström, F. Cooper, C. Perez, A. Diez Eastell, R. Hofbauer, L. C. Kanis, J. A. Langdahl, B. L. Lesnyak, O. Lorenc, R. McCloskey, E. Messina, O. D. Napoli, N. Obermayer-Pietsch, B. Ralston, S. H. Sambrook, P. N. Silverman, S. Sosa, M. Stepan, J. Suppan, G. Wahl, D. A. Compston, J. E.
Clasificación UNESCO:	32 Ciencias médicas 3207 Patología
Palabras clave:	Glucocorticoids Bone mineral density Fracture FRAX Bone protective therapy
Fecha de publicación:	2012
Publicación seriada:	Archives of Osteoporosis
Resumen:	The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
URI:	http://hdl.handle.net/10553/50717
ISSN:	1862-3522
DOI:	10.1007/s11657-012-0070-7
Fuente:	Archives of Osteoporosis[ISSN 1862-3522],v. 7, p. 25-30
Colección:	Artículos

Vista completa